Status:
UNKNOWN
Peripheral Avascular Retina in Retinopathy of Prematurity
Lead Sponsor:
Assiut University
Conditions:
Retinopathy of Prematurity
Eligibility:
All Genders
18-3 years
Phase:
NA
Brief Summary
Retinopathy of prematurity (ROP) is a widely known retinal vascular disorder in preterm infants and a leading cause of visual disability or blindness in children. Advances in antenatal care have resul...
Detailed Description
The natural history of peripheral nonperfusion and vascular abnormalities, which persist beyond the acute phase of ROP, remains poorly understood. Although patients with a history of type I ROP (treat...
Eligibility Criteria
Inclusion
- Patients with persistent peripheral avascular retina attending follow up till the age of 18 months in the core study whether;
- regressed ROP: children with regressed ROP who had not received any treatment.
- IVI treatment ROP: children with a history of threshold ROP treated with IVI of anti-VEGF agents.
Exclusion
- Eyes with previous laser therapy.
- Eyes with any other pathology, other than ROP.
- Eyes with stage 4 or 5 ROP.
- Patients with hypersensitivity to iodinated contrast media, liver and renal insufficiency, history of asthma.
- Patients who will show hypersensitivity reaction to fluorescein angiography will be excluded from the thesis.
- Patients unfit for general anesthesia.
Key Trial Info
Start Date :
January 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2025
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT06044181
Start Date
January 1 2024
End Date
November 1 2025
Last Update
May 13 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assiut University Hospital
Asyut, Egypt, 088